Literature DB >> 18325508

Inappropriate gonadotropin secretion in polycystic ovary syndrome.

Ming-I Hsu1, Tsan-Hon Liou, So-Jung Liang, Hung-Wen Su, Chien-Hua Wu, Chun-Sen Hsu.   

Abstract

OBJECTIVE: To evaluate inappropriate gonadotropin secretion in women with polycystic ovary syndrome (PCOS).
DESIGN: Retrospective study.
SETTING: Academic tertiary center. PATIENT(S): A total of 373 women were classified into three groups: [1] healthy control women (n = 48); [2] women who were positive for PCOS risk factor; and [3] women with PCOS (n = 251). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Gonadotropin levels, LH-FSH ratio, body mass index, and clinical and/or biochemical presentations of PCOS. RESULT(S): The area under the receiver operating characteristic curve, used to predict PCOS for the LH-FSH ratio, showed similar diagnostic performance to total T and average ovarian volume. The LH-FSH ratio exhibits greater observed accuracy than total T and average ovarian volume for evaluation of women with oligomenorrhea or anovulation. An LH-FSH ratio of >1 presented the best combination of sensitivity and specificity. Body mass index was positively correlated with total T in non-PCOS and PCOS groups; however, body mass index was negatively correlated with LH in PCOS but showed no correlation in non-PCOS subjects. CONCLUSION(S): The LH-FSH ratio is a valuable diagnostic tool in evaluating women with PCOS and oligomenorrhea or anovulation, and an LH-FSH ratio of >1 may be used as a decision threshold. The link between body mass index and LH may provide clues for further understanding the pathological milieu of PCOS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325508     DOI: 10.1016/j.fertnstert.2008.01.036

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain.

Authors:  Jamal Golbahar; Maha Al-Ayadhi; Negalla Mohan Das; Khalid Gumaa
Journal:  Int J Womens Health       Date:  2012-05-11

Review 2.  Clinical characteristics in Taiwanese women with polycystic ovary syndrome.

Authors:  Ming-I Hsu
Journal:  Clin Exp Reprod Med       Date:  2015-09-30

3.  Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.

Authors:  Sungwook Chun
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

4.  Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome.

Authors:  Chan-Hong Park; Sungwook Chun
Journal:  Obstet Gynecol Sci       Date:  2016-11-15

5.  Single-Cell Transcriptomic Analysis Reveals Mitochondrial Dynamics in Oocytes of Patients With Polycystic Ovary Syndrome.

Authors:  Lingbin Qi; Boxuan Liu; Xian Chen; Qiwei Liu; Wanqiong Li; Bo Lv; Xiaoyu Xu; Lu Wang; Qiao Zeng; Jinfeng Xue; Zhigang Xue
Journal:  Front Genet       Date:  2020-04-30       Impact factor: 4.599

Review 6.  Efficacy of Flavonoids on Animal Models of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Jiacheng Zhang; Haolin Zhang; Xiyan Xin; Yutian Zhu; Yang Ye; Dong Li
Journal:  Nutrients       Date:  2022-10-04       Impact factor: 6.706

7.  Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome.

Authors:  Afsane Ahmadi; Marzieh Akbarzadeh; Fatemeh Mohammadi; Marzieh Akbari; Bahareh Jafari; Hamid Reza Tolide-Ie
Journal:  Indian J Endocrinol Metab       Date:  2013-07

8.  GnRH Antagonist IVF Protocol in PCOS.

Authors:  Alina Onofriescu; A Bors; A Luca; M Holicov; M Onofriescu; Carmen Vulpoi
Journal:  Curr Health Sci J       Date:  2013-03-21

9.  Validation of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ).

Authors:  Chung-Ying Lin; Huang-Tz Ou; Meng-Hsing Wu; Pei-Chi Chen
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.